|
Rebrova D.V., Vorokhobina N.V.
Pegvisomant in the treatment of acromegaly
|
№2 / 2024
|
|
M.B. Antsiferov, A.V. Petryaikin, T.M. Alekseeva, E.V. Pronin, A.N. Khoruzhaya, S.M. Tamaeva
Modern possibilities of tumor-oriented diagnostics and treatment of acromegaly
|
№3 / 2023
|
|
I.A. Ilovayskaya, P.A. Zakharova, E.D. Metlushko
Monitoring of patients with acromegaly in the real-life clinical practice settings
|
№11-12 / 2022
|
|
E.V. Pronin, T.M. Alekseeva, M.B. Antsiferov
The efficacy of pegvisomant in patients with acromegaly resistant to 1st generation somatostatin analogues
|
№4 / 2022
|
|
E.V. Pronin (1), M.B. Antsiferov (1), T.M. Alekseeva (1), L.S. Urusova (2), A.M. Lapshina (2), N.G. Mokrysheva (2)
Optimization of drug treatment of acromegaly (clinical and morphological comparison)
|
№4 / 2022
|
|
A.E. Goldshmid (1), E.Yu. Martynova (1), Yu.E. Poteshkin (2)
Clinical case of the use of the long-acting somatostatin analogue in a patient with acromegaly who has not achieved clinical and laboratory remission after telegrammatherapy
|
№4 / 2019
|
|
M.B. Antsiferov (1), T.M. Alekseeva (1), A.V. Andreeva (2)
Current approaches to the diagnostics and treatment of acromegaly
|
№4 / 2019
|
|
M.B. Antsiferov (1), Zh.E. Belaya (2)
INCREASING THE DOSE OF SOMATOSTATIN ANALOGUES OF IN PATIENTS WITH ACTIVE FORM OF ACROMEGALY: LITERATURE REVIEW AND PROSPECTS FOR APPLICATION
|
№16 / 2017
|
|
M.B. Antsiferov (1), V.S. Pronin (2)
STRATEGY OF ACTIVE SEARCH FOR PATIENTS WITH ACROMEGALY: CASE REPORT
|
№5 / 2017
|
|
M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
MOSCOW REGISTRY OF PATIENTS WITH ACROMEGALY: LONG-TERM RESULTS OF OBSERVATIONS
|
№16 / 2016
|
|
M.B. Antsiferov (1), V.S.Pronin (2)
THE USE OF CLINICAL AND LABORATORY PREDICTORS FOR PROGNOSTICATION OF ANTISECRETORY AND ANTIPROLIFERATIVE EFFECTS OF SOMATOSTATIN ANALOGUES DURING THE TREATMENT OF ACROMEGALY: REVIEW OF RECENT RESEARCH
|
№5 / 2015
|
|
M.B. Antsiferov (1), V.S. Pronin (2)
OPTIMIZATION OF TREATMENT OF PATIENTS WITH ACROMEGALY: INCREASE THE INTERVAL BETWEEN INJECTIONS OF LANREOTIDE
|
№16 / 2014
|
Русский
